Myriad Genetics, Inc. (MYGN)
3.05
-0.15
(-4.69%)
USD |
NASDAQ |
Aug 24, 16:00
3.04
-0.01
(-0.33%)
Pre-Market: 20:00
Myriad Genetics Net Income (Quarterly) : -43.20M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -43.20M |
| March 31, 2026 | -34.10M |
| December 31, 2025 | -7.90M |
| September 30, 2025 | -27.40M |
| June 30, 2025 | -330.50M |
| March 31, 2025 | -0.10M |
| December 31, 2024 | -42.50M |
| September 30, 2024 | -22.10M |
| June 30, 2024 | -36.70M |
| March 31, 2024 | -26.00M |
| December 31, 2023 | -31.20M |
| September 30, 2023 | -61.30M |
| June 30, 2023 | -116.10M |
| March 31, 2023 | -54.70M |
| December 31, 2022 | -42.30M |
| September 30, 2022 | -35.10M |
| June 30, 2022 | -14.10M |
| March 31, 2022 | -20.50M |
| December 31, 2021 | -7.60M |
| September 30, 2021 | 24.60M |
| June 30, 2021 | -4.70M |
| March 31, 2021 | -39.50M |
| June 30, 2020 | -55.50M |
| March 31, 2020 | -115.20M |
| December 31, 2019 | -8.30M |
| Date | Value |
|---|---|
| September 30, 2019 | -20.60M |
| June 30, 2019 | -4.30M |
| March 31, 2019 | 6.90M |
| December 31, 2018 | 2.60M |
| September 30, 2018 | -0.80M |
| June 30, 2018 | 14.50M |
| March 31, 2018 | 9.00M |
| December 31, 2017 | 30.90M |
| September 30, 2017 | 78.70M |
| June 30, 2017 | 12.70M |
| March 31, 2017 | 4.20M |
| December 31, 2016 | 5.90M |
| September 30, 2016 | -1.20M |
| June 30, 2016 | 23.40M |
| March 31, 2016 | 34.50M |
| December 31, 2015 | 30.30M |
| September 30, 2015 | 26.60M |
| June 30, 2015 | 18.70M |
| March 31, 2015 | 21.48M |
| December 31, 2014 | 24.03M |
| September 30, 2014 | 15.98M |
| June 30, 2014 | 33.63M |
| March 31, 2014 | 36.77M |
| December 31, 2013 | 50.36M |
| September 30, 2013 | 55.46M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Natera, Inc. | -66.97M |
| Sera Prognostics, Inc. | -9.139M |
| BioRestorative Therapies, Inc. | -2.154M |
| CareDx, Inc. | 110.64M |
| Exagen, Inc. | -3.196M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 190.70M |
| Total Expenses (Quarterly) | 233.90M |
| EPS Diluted (Quarterly) | -0.4557 |
| Enterprise Value | 386.88M |
| Gross Profit Margin (Quarterly) | 62.51% |
| Profit Margin (Quarterly) | -22.65% |
| Earnings Yield | -39.30% |
| Normalized Earnings Yield | -37.31 |